Microbial function and genital inflammation in young South African women at high risk of HIV infection.
Cytokine
Female genital tract
Inflammation
Metaproteomics
Microbial function
Microbiome
Journal
Microbiome
ISSN: 2049-2618
Titre abrégé: Microbiome
Pays: England
ID NLM: 101615147
Informations de publication
Date de publication:
21 11 2020
21 11 2020
Historique:
received:
30
06
2020
accepted:
06
10
2020
entrez:
22
11
2020
pubmed:
23
11
2020
medline:
2
4
2021
Statut:
epublish
Résumé
Female genital tract (FGT) inflammation is an important risk factor for HIV acquisition. The FGT microbiome is closely associated with inflammatory profile; however, the relative importance of microbial activities has not been established. Since proteins are key elements representing actual microbial functions, this study utilized metaproteomics to evaluate the relationship between FGT microbial function and inflammation in 113 young and adolescent South African women at high risk of HIV infection. Women were grouped as having low, medium, or high FGT inflammation by K-means clustering according to pro-inflammatory cytokine concentrations. A total of 3186 microbial and human proteins were identified in lateral vaginal wall swabs using liquid chromatography-tandem mass spectrometry, while 94 microbial taxa were included in the taxonomic analysis. Both metaproteomics and 16S rRNA gene sequencing analyses showed increased non-optimal bacteria and decreased lactobacilli in women with FGT inflammatory profiles. However, differences in the predicted relative abundance of most bacteria were observed between 16S rRNA gene sequencing and metaproteomics analyses. Bacterial protein functional annotations (gene ontology) predicted inflammatory cytokine profiles more accurately than bacterial relative abundance determined by 16S rRNA gene sequence analysis, as well as functional predictions based on 16S rRNA gene sequence data (p < 0.0001). The majority of microbial biological processes were underrepresented in women with high inflammation compared to those with low inflammation, including a Lactobacillus-associated signature of reduced cell wall organization and peptidoglycan biosynthesis. This signature remained associated with high FGT inflammation in a subset of 74 women 9 weeks later, was upheld after adjusting for Lactobacillus relative abundance, and was associated with in vitro inflammatory cytokine responses to Lactobacillus isolates from the same women. Reduced cell wall organization and peptidoglycan biosynthesis were also associated with high FGT inflammation in an independent sample of ten women. Both the presence of specific microbial taxa in the FGT and their properties and activities are critical determinants of FGT inflammation. Our findings support those of previous studies suggesting that peptidoglycan is directly immunosuppressive, and identify a possible avenue for biotherapeutic development to reduce inflammation in the FGT. To facilitate further investigations of microbial activities, we have developed the FGT-DB application that is available at http://fgtdb.org/ . Video Abstract.
Sections du résumé
BACKGROUND
Female genital tract (FGT) inflammation is an important risk factor for HIV acquisition. The FGT microbiome is closely associated with inflammatory profile; however, the relative importance of microbial activities has not been established. Since proteins are key elements representing actual microbial functions, this study utilized metaproteomics to evaluate the relationship between FGT microbial function and inflammation in 113 young and adolescent South African women at high risk of HIV infection. Women were grouped as having low, medium, or high FGT inflammation by K-means clustering according to pro-inflammatory cytokine concentrations.
RESULTS
A total of 3186 microbial and human proteins were identified in lateral vaginal wall swabs using liquid chromatography-tandem mass spectrometry, while 94 microbial taxa were included in the taxonomic analysis. Both metaproteomics and 16S rRNA gene sequencing analyses showed increased non-optimal bacteria and decreased lactobacilli in women with FGT inflammatory profiles. However, differences in the predicted relative abundance of most bacteria were observed between 16S rRNA gene sequencing and metaproteomics analyses. Bacterial protein functional annotations (gene ontology) predicted inflammatory cytokine profiles more accurately than bacterial relative abundance determined by 16S rRNA gene sequence analysis, as well as functional predictions based on 16S rRNA gene sequence data (p < 0.0001). The majority of microbial biological processes were underrepresented in women with high inflammation compared to those with low inflammation, including a Lactobacillus-associated signature of reduced cell wall organization and peptidoglycan biosynthesis. This signature remained associated with high FGT inflammation in a subset of 74 women 9 weeks later, was upheld after adjusting for Lactobacillus relative abundance, and was associated with in vitro inflammatory cytokine responses to Lactobacillus isolates from the same women. Reduced cell wall organization and peptidoglycan biosynthesis were also associated with high FGT inflammation in an independent sample of ten women.
CONCLUSIONS
Both the presence of specific microbial taxa in the FGT and their properties and activities are critical determinants of FGT inflammation. Our findings support those of previous studies suggesting that peptidoglycan is directly immunosuppressive, and identify a possible avenue for biotherapeutic development to reduce inflammation in the FGT. To facilitate further investigations of microbial activities, we have developed the FGT-DB application that is available at http://fgtdb.org/ . Video Abstract.
Identifiants
pubmed: 33220709
doi: 10.1186/s40168-020-00932-8
pii: 10.1186/s40168-020-00932-8
pmc: PMC7679981
doi:
Substances chimiques
RNA, Ribosomal, 16S
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Video-Audio Media
Langues
eng
Sous-ensembles de citation
IM
Pagination
165Commentaires et corrections
Type : ErratumIn
Références
Am J Reprod Immunol. 2015 Oct;74(4):357-67
pubmed: 26202107
Nat Methods. 2016 Jul;13(7):581-3
pubmed: 27214047
Nat Rev Microbiol. 2018 Jun 24;16:540-550
pubmed: 29937540
Sex Transm Infect. 2018 Mar;94(2):117-123
pubmed: 28947665
Sci Rep. 2018 Jul 23;8(1):11109
pubmed: 30038262
Nature. 2009 Apr 23;458(7241):1034-8
pubmed: 19262509
PLoS Pathog. 2016 Sep 22;12(9):e1005889
pubmed: 27656899
Front Cell Infect Microbiol. 2020 Mar 31;10:117
pubmed: 32296647
Mucosal Immunol. 2017 Nov;10(6):1480-1490
pubmed: 28401934
Mucosal Immunol. 2016 Jan;9(1):194-205
pubmed: 26104913
J Acquir Immune Defic Syndr. 2014 Jun 1;66(2):109-17
pubmed: 24413042
Sex Transm Infect. 2014 Dec;90(8):580-7
pubmed: 25107710
Microb Cell Fact. 2014 Aug 29;13 Suppl 1:S9
pubmed: 25186919
BMC Genomics. 2020 Jan 17;21(1):56
pubmed: 31952477
PLoS One. 2019 Apr 4;14(4):e0213975
pubmed: 30947260
Gut. 2011 Aug;60(8):1050-9
pubmed: 21471573
Gut Microbes. 2011 Sep 1;2(5):280-6
pubmed: 22067939
Immunity. 2017 Jan 17;46(1):29-37
pubmed: 28087240
Trends Microbiol. 2013 Jul;21(7):334-41
pubmed: 23685069
Bioinformatics. 2016 Sep 15;32(18):2847-9
pubmed: 27207943
Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4680-7
pubmed: 20534435
PLoS Comput Biol. 2017 Nov 3;13(11):e1005752
pubmed: 29099853
Clin Infect Dis. 2015 Jul 15;61(2):260-9
pubmed: 25900168
Sci Rep. 2019 Feb 13;9(1):1917
pubmed: 30760770
mBio. 2014 Jul 08;5(4):e01283-14
pubmed: 25006228
Science. 2017 Jun 2;356(6341):938-945
pubmed: 28572388
Proc Natl Acad Sci U S A. 1989 Apr;86(7):2336-40
pubmed: 2494664
BMC Microbiol. 2009 Jun 02;9:116
pubmed: 19490622
Sci Rep. 2018 Jul 18;8(1):10868
pubmed: 30022083
Immunity. 2015 May 19;42(5):965-76
pubmed: 25992865
AIDS Res Hum Retroviruses. 2019 Mar;35(3):219-228
pubmed: 30638028
Nat Med. 2018 May;24(4):491-496
pubmed: 29480895
Proteomics. 2015 Oct;15(20):3424-38
pubmed: 25914197
Sci Rep. 2020 Apr 10;10(1):6196
pubmed: 32277092
Int J Mol Sci. 2015 Mar 12;16(3):5803-29
pubmed: 25775160
J Proteome Res. 2011 Nov 4;10(11):5139-49
pubmed: 21973077
BMC Bioinformatics. 2008 Dec 29;9:559
pubmed: 19114008
Int J STD AIDS. 2018 May;29(6):531-539
pubmed: 29198180
Infect Immun. 2017 Dec 19;86(1):
pubmed: 29038128